AIMCA
FPRX

Alberta Investment Management Corp (AIMCo)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-132,200
Closed -$4.98M – 1076
2021
Q1 		$4.98M Buy
+132,200
New +$3.3M 0.04% 367

Alberta Investment Management Corp (AIMCo)'s FPRX Position: Q2 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 132,200 shares — an estimated $4.98M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $4.98M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 132,200 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $4.98M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Five Prime Therapeutics, Inc. position peaked at $4.98M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2021, filed 16 Aug 2021.